Search Results - "Adlard, N"

Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis by Yeo, L, Adlard, N, Biehl, M, Juarez, M, Smallie, T, Snow, M, Buckley, C D, Raza, K, Filer, A, Scheel-Toellner, D

“…For our understanding of the pathogenesis of rheumatoid arthritis (RA), it is important to elucidate the mechanisms underlying early stages of synovitis. Here,…”
Get more information

Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial by Adlard, Kirsten N, Jenkins, David G, Salisbury, Chloe E, Bolam, Kate A, Gomersall, Sjaan R, Aitken, Joanne F, Chambers, Suzanne K, Dunn, Jeff C, Courneya, Kerry S, Skinner, Tina L

“…Despite an overwhelming body of evidence showing the benefits of physical activity (PA) and exercise for cancer survivors, few survivors meet the exercise…”
Get full text

The relationship between BPAQ-derived physical activity and bone density of middle-aged and older men by Bolam, K. A., Beck, B. R., Adlard, K. N., Skinner, T. L., Cormie, P., Galvão, D. A., Spry, N., Newton, R. U., Taaffe, D. R.

“…Summary The bone-specific physical activity questionnaire (BPAQ) accounts for activities that affect bone but has not been used in studies with older adults…”
Get full text

Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis by Maruszczak, M, Kusel, J, Adlard, N

Get full text

Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK by Kusel, J, Maruszczak, M, Montgomery, S, Allen, F, Adlard, N

Get full text

Health and Social Care Resource Use by Individuals with Fragile X Syndrome: Results of Two Delphi Panels by Barry, S.J, London, P, Bostock, T, Adlard, N, Lakhdari, K, Aubertin, G, Burge, P, Corbin, J.F, Gagnon, S, Hassiotis, A

Get full text

A Comparison of Bone Mineral Density in Amateur Male Boxers and Active Non-boxers by Bolam, K A, Skinner, T L, Sax, A T, Adlard, K N, Taaffe, D R

“…To examine the site-specific osteogenic effect of upper limb impact-loading activity we compared the forearm and arm bone mineral density (BMD) of male boxers…”
Get more information

Interleukin‐15 and high‐intensity exercise: relationship with inflammation, body composition and fitness in cancer survivors by Farley, Morgan J., Boytar, Alexander N., Adlard, Kirsten N., Salisbury, Chloe E., Hart, Nicolas H., Schaumberg, Mia A., Jenkins, David G., Skinner, Tina L.

“…Pre‐clinical murine and in vitro models have demonstrated that exercise suppresses tumour and cancer cell growth. These anti‐oncogenic effects of exercise were…”
Get full text

Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple Myeloma by Nicol, Jennifer L., Cunningham, Brent J., WOODROW, CARMEL, ADLARD, KIRSTEN N., PAPINCZAK, ZOE E., SPENCE, ROSALIND R., BOYTAR, ALEXANDER N., MOLLEE, PETER, WEBER, NICHOLAS, NICOL, ANDREW J., HILL, MICHELLE M., SKINNER, TINA L.

“…ABSTRACT Introduction High rates of disease- and treatment-related symptoms, such as bone lesions, in people with multiple myeloma (MM) create uncertainty on…”
Get full text

PND61 - Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model by Kusel, J, Maruszczak, M, Adlard, N

Get full text

Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model by Kusel, J, Maruszczak, M, Adlard, N

Get full text

Modelling Disability Progression in Patients with Secondary Progressive Multiple Sclerosis Shows Non-linearity of EDSS Changes over Time (4091) by Bezlyak, Vladimir, Forsberg, Lars, Klyve, Pernilla, Adlard, Nicholas, Hach, Thomas, Lines, Carol, Glaser, Anna, Hillert, Jan

“…Abstract only…”
Get full text

Pnd49 - Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis by Maruszczak, M., Kusel, J., Adlard, N.

Get full text

A Three Month Interim Analysis of Treatment Satisfaction with Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis in the UK: The Patient Reported Outcomes with Fingolimod in Local Experience (Profile) Study by Adlard, N, Brisbane, F, Watson, J, Bishop-Bailey, A, Kroes, M

“…OBJECTIVES:The PROI'lLE study measured patient reported outcomes (PROs) in the real world in fingolimod treated patients with relapsing remitting multiple…”
Get full text

PND62 - A Three Month Interim Analysis of Treatment Satisfaction with Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis in the UK: The Patient Reported Outcomes with Fingolimod in Local Experience (Profile) Study by Adlard, N, Brisbane, F, Watson, J, Bishop-Bailey, A, Kroes, M

Get full text

Objective classification of multiple sclerosis disease course results in frequent reclassification to secondary progressive multiple sclerosis (4094) by Hillert, Jan, Forsberg, Lars, Manouchehrinia, Ali, Ramanujam, Ryan, Spelman, Timothy, Klyve, Pernilla, Drahota, Jiri, Horakova, Dana, Joensen, Hanna, Magyari, Melinda, Ellenberger, David, Stahmann, Alexander, Van Der Walt, Anneke, Rodgers, Jeff, Witts, James A., Middleton, Rod, Nicholas, Richard, Bezlyak, Vladimir, Adlard, Nicholas, Hach, Thomas, Lines, Carol, Glaser, Anna

“…Abstract only…”
Get full text

PRM28 - Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK by Kusel, J., Maruszczak, M., Montgomery, S., Allen, F., Adlard, N.

Get full text

Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease by Gustavsson, Anders, Green, Colin, Jones, Roy W, Förstl, Hans, Simsek, Deniz, de Reydet de Vulpillieres, Frederic, Luthman, Stefanie, Adlard, Nicholas, Bhattacharyya, Subrata, Wimo, Anders

“…Abstract Introduction Available data and models for the health-economic evaluation of treatment in Alzheimer's disease (AD) have limitations causing…”
Get full text

Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study by Benedict, Ralph H B, Vo, Pamela, Adlard, Nicholas, Grennan, Olwyn, Enstone, Ashley, Bridge, Daisy, Wyn, Robin, Cohan, Stanley L

“…Cognitive impairment, especially relating to cognitive processing speed, is a major cause of disability in people with multiple sclerosis (MS). Utility values…”
Get full text

UK PATIENT PREFERENCE FOR CHARACTERISTICS OF DMTS IN MS by Bottomley, Catherine, Padania, Sheetal, Lloyd, Andrew, Gary, Bennett, Green, Colin, Adlard, Nicholas

“…With recent Disease Modifying Treatments (DMTs) licensed in Multiple Sclerosis (MS), treatment options are increasing. NICE has suggested that patient…”
Get full text